David Winpenny

David Winpenny

Principal Scientist

Pfizer Neusentis

Speaker

Presentations at Drug Discovery 2015

Wed2 Sep11:00am(30 mins)	Biased Ligand Quantification in Drug Discovery: From Theory to High Throughput Screening to Identify New Biased µ Opioid Receptor Agonists
	Session: Innovation in Assay Development & Screening Room: Ironbridge

Profile of David Winpenny

David Winpenny is a Principal Scientist at Pfizer Neusentis in Cambridge UK. He has over 20 years experience within assay development, screening and data analysis across a range of target classes including GPCRS, RTKs, transporters and ion channels.

Email

Please login to send a Private Message

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'

Privacy Notice